MedPath

OCT and Invasion in Cutaneous Skin Lesions

Completed
Conditions
Cutaneous Squamous Cell Carcinoma
Keratosis, Actinic
Bowen's Disease
Actinic Keratoses
Diagnosis
Interventions
Diagnostic Test: Optical Coherence Tomography
Other: Clinical assessment
Registration Number
NCT06014697
Lead Sponsor
Maastricht University Medical Center
Brief Summary

The increasing incidence of actinic keratosis (AK), morbus Bowen (MB) and cutaneous squamous cell carcinoma (cSCC), the patients with often multiple lesions and the disadvantages of invasive diagnostics show the need for an accurate non-invasive diagnostic tool for the determination of invasive growth in AK and MB.

Optical coherence tomography (OCT) is a non-invasive scanner creating cross-sectional images of the skin, to a depth of 1-1,5 mm based on light waves. Until now, OCT has been proposed as non-invasive diagnostic tool for basal cell carcinomas. Although the diagnostic value of OCT for detection and sub-typing of basal cell carcinomas has already been demonstrated, it is unclear whether OCT can discriminate between invasive and non-invasive lesions (AK, MB and cSCCs). There are some studies that describe OCT characteristics of AK, MB and cSCCs, however, these characteristics have a lot of overlap (8-13). To date there are no clearly distinctive OCT features to distinguish between AK, MB and cSCCs. This study aims to investigate the value of OCT in discriminating between the presence and absence of invasion in lesions with clinical suspicion for invasion.

Two experienced OCT-assessors will evaluate the OCT scans independently. The OCT assessors are blinded to the histological diagnosis of the lesions (invasive or non-invasive), which is used as golden standard.

A 5-point Likert scale is used for OCT assessment.

1. Definitely not invasive

2. Probably not invasive

3. Unknown, probably invasive/probably not invasive

4. Probably invasive

5. Definitely invasive

In addition to completing the Likert-scale, assessors are asked to describe the presence/absence of predefined OCT characteristics (a.o. hyperkeratosis and the presence of the dermo-epidermal junction)

In case of disagreement between the independent assessors, the OCT scan will be re-assessed in a consensus meeting.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  • Patients who are included in a previous study on OCT, with written informed consent to use their data regarding OCT.
  • Patients who retrospectively had an OCT scan for their skin lesion
  • With a histological confirmed actinic keratosis, bowens disease or cutaneous squamous cell carcinoma of the skin
  • with a differential diagnosis of a invasive lesion (cutaneous squamous cell carcinoma) and a non-invasive lesion (bowens disease or actinic keratosis).
Exclusion Criteria
  • patients who waived informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Non-invasive lesionClinical assessmentLesion with histological confirmation of a actinic keratosis or Bowens disease (non-invasive lesions).
Invasive lesionClinical assessmentLesion with histological confirmation of a squamous cell carcinoma (invasive lesions).
Non-invasive lesionOptical Coherence TomographyLesion with histological confirmation of a actinic keratosis or Bowens disease (non-invasive lesions).
Invasive lesionOptical Coherence TomographyLesion with histological confirmation of a squamous cell carcinoma (invasive lesions).
Primary Outcome Measures
NameTimeMethod
SensitivityThrough study completion, an average of 6 months

Sensitivity of OCT to detect invasion

SpecificityThrough study completion, an average of 6 months

Specificity of OCT in determining the presence/absence of invasion

Secondary Outcome Measures
NameTimeMethod
Negative predictive value of OCT featuresThrough study completion, an average of 6 months

Negative predictive value for specific OCT-features characteristic for the presence/absence of invasion, such as presence/absence of the dermo-epidermal junction or presence/absence of hyperkeratosis.

Area under the curveThrough study completion, an average of 6 months

Area under the curve for OCT in determining the presence/absence of invasion

Specificity of OCT featuresThrough study completion, an average of 6 months

Specificity for specific OCT-features characteristic for the presence/absence of invasion, such as presence/absence of the dermo-epidermal junction or presence/absence of hyperkeratosis.

Area under the curve for OCT featuresThrough study completion, an average of 6 months

Area under the curve for specific OCT-features characteristic for the presence/absence of invasion, such as presence/absence of the dermo-epidermal junction or presence/absence of hyperkeratosis.

Negative predictive valueThrough study completion, an average of 6 months

Negative predictive value of OCT in determining the presence/absence of invasion

Positive predictive valueThrough study completion, an average of 6 months

Positive predictive value of OCT in determining the presence/absence of invasion

Sensitivity of OCT featuresThrough study completion, an average of 6 months

Sensitivity for specific OCT-features characteristic for the presence/absence of invasion, such as presence/absence of the dermo-epidermal junction or presence/absence of hyperkeratosis.

Difference OCT and clinical practiceThrough study completion, an average of 6 months

Difference in diagnostic parameters (sensitivity, specificity and area under the curve) between OCT and clinical practice (clinical assessment).

Positive predictive value of OCT featuresThrough study completion, an average of 6 months

Positive predictive value for specific OCT-features characteristic for the presence/absence of invasion, such as presence/absence of the dermo-epidermal junction or presence/absence of hyperkeratosis.

Trial Locations

Locations (1)

Maastricht University Medical Center+

🇳🇱

Maastricht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath